Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 187 entries
Sorted by: Best Match Show Resources per page
Role of Adjuvant Therapy in Esophageal Cancer Patients after Neoadjuvant Therapy and Esophagectomy: A Systematic Review and Meta-Analysis.

Annals of surgery

Lee Y, Samarasinghe Y, Lee MH, Thiru L, Shargall Y, Finley C, Hanna W, Levine O, Juergens R, Agzarian J.
PMID: 34596073
Ann Surg. 2021 Sep 29; doi: 10.1097/SLA.0000000000005227. Epub 2021 Sep 29.

OBJECTIVE: To analyze esophageal cancer patients who previously underwent neoadjuvant therapy followed by a curative resection to determine whether additional adjuvant therapy is associated with improved survival outcomes.SUMMARY BACKGROUND DATA: Neoadjuvant therapy followed by surgery is the standard of...

Cite
Lee Y, Samarasinghe Y, Lee MH, et al. Role of Adjuvant Therapy in Esophageal Cancer Patients after Neoadjuvant Therapy and Esophagectomy: A Systematic Review and Meta-Analysis. Ann Surg. 2021;doi: 10.1097/SLA.0000000000005227.
Lee, Y., Samarasinghe, Y., Lee, M. H., Thiru, L., Shargall, Y., Finley, C., Hanna, W., Levine, O., Juergens, R., & Agzarian, J. (2021). Role of Adjuvant Therapy in Esophageal Cancer Patients after Neoadjuvant Therapy and Esophagectomy: A Systematic Review and Meta-Analysis. Annals of surgery, . https://doi.org/10.1097/SLA.0000000000005227
Lee, Yung, et al. "Role of Adjuvant Therapy in Esophageal Cancer Patients after Neoadjuvant Therapy and Esophagectomy: A Systematic Review and Meta-Analysis." Annals of surgery vol. (2021). doi: https://doi.org/10.1097/SLA.0000000000005227
Lee Y, Samarasinghe Y, Lee MH, Thiru L, Shargall Y, Finley C, Hanna W, Levine O, Juergens R, Agzarian J. Role of Adjuvant Therapy in Esophageal Cancer Patients after Neoadjuvant Therapy and Esophagectomy: A Systematic Review and Meta-Analysis. Ann Surg. 2021 Sep 29; doi: 10.1097/SLA.0000000000005227. Epub 2021 Sep 29. PMID: 34596073.
Copy Download .nbib Format: NLM
Quantitative .

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Ortega C, Wong RKS, Schaefferkoetter J, Veit-Haibach P, Myrehaug S, Juergens R, Laidley D, Anconina R, Liu A, Metser U.
PMID: 33579805
J Nucl Med. 2021 Oct;62(10):1406-1414. doi: 10.2967/jnumed.120.256727. Epub 2021 Feb 12.

The aim of this study was to determine whether quantitative PET parameters on baseline

Cite
Ortega C, Wong RKS, Schaefferkoetter J, et al. Quantitative . J Nucl Med. 2021;62(10):1406-1414doi: 10.2967/jnumed.120.256727.
Ortega, C., Wong, R. K. S., Schaefferkoetter, J., Veit-Haibach, P., Myrehaug, S., Juergens, R., Laidley, D., Anconina, R., Liu, A., & Metser, U. (2021). Quantitative . Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 62(10), 1406-1414. https://doi.org/10.2967/jnumed.120.256727
Ortega, Claudia, et al. "Quantitative ." Journal of nuclear medicine : official publication, Society of Nuclear Medicine vol. 62,10 (2021): 1406-1414. doi: https://doi.org/10.2967/jnumed.120.256727
Ortega C, Wong RKS, Schaefferkoetter J, Veit-Haibach P, Myrehaug S, Juergens R, Laidley D, Anconina R, Liu A, Metser U. Quantitative . J Nucl Med. 2021 Oct;62(10):1406-1414. doi: 10.2967/jnumed.120.256727. Epub 2021 Feb 12. PMID: 33579805.
Copy Download .nbib Format: NLM
Role of Adjuvant Therapy in Esophageal Cancer Patients After Neoadjuvant Therapy and Esophagectomy: A Systematic Review and Meta-analysis.

Annals of surgery

Lee Y, Samarasinghe Y, Lee MH, Thiru L, Shargall Y, Finley C, Hanna W, Levine O, Juergens R, Agzarian J.
PMID: 34596073
Ann Surg. 2022 Jan 01;275(1):91-98. doi: 10.1097/SLA.0000000000005227.

OBJECTIVE: The aim of this study was to analyze esophageal cancer patients who previously underwent neoadjuvant therapy followed by a curative resection to determine whether additional adjuvant therapy is associated with improved survival outcomes.SUMMARY BACKGROUND DATA: Neoadjuvant therapy followed...

Cite
Lee Y, Samarasinghe Y, Lee MH, et al. Role of Adjuvant Therapy in Esophageal Cancer Patients After Neoadjuvant Therapy and Esophagectomy: A Systematic Review and Meta-analysis. Ann Surg. 2022;275(1):91-98doi: 10.1097/SLA.0000000000005227.
Lee, Y., Samarasinghe, Y., Lee, M. H., Thiru, L., Shargall, Y., Finley, C., Hanna, W., Levine, O., Juergens, R., & Agzarian, J. (2022). Role of Adjuvant Therapy in Esophageal Cancer Patients After Neoadjuvant Therapy and Esophagectomy: A Systematic Review and Meta-analysis. Annals of surgery, 275(1), 91-98. https://doi.org/10.1097/SLA.0000000000005227
Lee, Yung, et al. "Role of Adjuvant Therapy in Esophageal Cancer Patients After Neoadjuvant Therapy and Esophagectomy: A Systematic Review and Meta-analysis." Annals of surgery vol. 275,1 (2022): 91-98. doi: https://doi.org/10.1097/SLA.0000000000005227
Lee Y, Samarasinghe Y, Lee MH, Thiru L, Shargall Y, Finley C, Hanna W, Levine O, Juergens R, Agzarian J. Role of Adjuvant Therapy in Esophageal Cancer Patients After Neoadjuvant Therapy and Esophagectomy: A Systematic Review and Meta-analysis. Ann Surg. 2022 Jan 01;275(1):91-98. doi: 10.1097/SLA.0000000000005227. PMID: 34596073.
Copy Download .nbib Format: NLM
Combination Treatment with Cold Physical Plasma and Pulsed Electric Fields Augments ROS Production and Cytotoxicity in Lymphoma.

Cancers

Wolff CM, Kolb JF, Weltmann KD, von Woedtke T, Bekeschus S.
PMID: 32244543
Cancers (Basel). 2020 Mar 31;12(4). doi: 10.3390/cancers12040845.

New approaches in oncotherapy rely on the combination of different treatments to enhance the efficacy of established monotherapies. Pulsed electric fields (PEFs) are an established method (electrochemotherapy) for enhancing cellular drug uptake while cold physical plasma is an emerging...

Cite
Wolff CM, Kolb JF, Weltmann KD, et al. Combination Treatment with Cold Physical Plasma and Pulsed Electric Fields Augments ROS Production and Cytotoxicity in Lymphoma. Cancers (Basel). 2020;12(4)doi: 10.3390/cancers12040845.
Wolff, C. M., Kolb, J. F., Weltmann, K. D., von Woedtke, T., & Bekeschus, S. (2020). Combination Treatment with Cold Physical Plasma and Pulsed Electric Fields Augments ROS Production and Cytotoxicity in Lymphoma. Cancers, 12(4), . https://doi.org/10.3390/cancers12040845
Wolff, Christina M, et al. "Combination Treatment with Cold Physical Plasma and Pulsed Electric Fields Augments ROS Production and Cytotoxicity in Lymphoma." Cancers vol. 12,4 (2020). doi: https://doi.org/10.3390/cancers12040845
Wolff CM, Kolb JF, Weltmann KD, von Woedtke T, Bekeschus S. Combination Treatment with Cold Physical Plasma and Pulsed Electric Fields Augments ROS Production and Cytotoxicity in Lymphoma. Cancers (Basel). 2020 Mar 31;12(4). doi: 10.3390/cancers12040845. PMID: 32244543; PMCID: PMC7226014.
Copy Download .nbib Format: NLM
Susceptibility of swine cells and domestic pigs to SARS-CoV-2.

bioRxiv : the preprint server for biology

Meekins DA, Morozov I, Trujillo JD, Gaudreault NN, Bold D, Artiaga BL, Indran SV, Kwon T, Balaraman V, Madden DW, Feldmann H, Henningson J, Ma W, Balasuriya UBR, Richt JA.
PMID: 32817946
bioRxiv. 2020 Aug 16; doi: 10.1101/2020.08.15.252395.

The emergence of SARS-CoV-2 has resulted in an ongoing global pandemic with significant morbidity, mortality, and economic consequences. The susceptibility of different animal species to SARS-CoV-2 is of concern due to the potential for interspecies transmission, and the requirement...

Cite
Meekins DA, Morozov I, Trujillo JD, et al. Susceptibility of swine cells and domestic pigs to SARS-CoV-2. bioRxiv. 2020;doi: 10.1101/2020.08.15.252395.
Meekins, D. A., Morozov, I., Trujillo, J. D., Gaudreault, N. N., Bold, D., Artiaga, B. L., Indran, S. V., Kwon, T., Balaraman, V., Madden, D. W., Feldmann, H., Henningson, J., Ma, W., Balasuriya, U. B. R., & Richt, J. A. (2020). Susceptibility of swine cells and domestic pigs to SARS-CoV-2. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2020.08.15.252395
Meekins, David A, et al. "Susceptibility of swine cells and domestic pigs to SARS-CoV-2." bioRxiv : the preprint server for biology vol. (2020). doi: https://doi.org/10.1101/2020.08.15.252395
Meekins DA, Morozov I, Trujillo JD, Gaudreault NN, Bold D, Artiaga BL, Indran SV, Kwon T, Balaraman V, Madden DW, Feldmann H, Henningson J, Ma W, Balasuriya UBR, Richt JA. Susceptibility of swine cells and domestic pigs to SARS-CoV-2. bioRxiv. 2020 Aug 16; doi: 10.1101/2020.08.15.252395. PMID: 32817946; PMCID: PMC7430576.
Copy Download .nbib Format: NLM
Correction to: Allogeneic hematopoietic stem cell transplantation in two brothers with DNA ligase IV deficiency: a case report and review of the literature.

BMC pediatrics

Schober S, Schilbach K, Doering M, Cabanillas Stanchi KM, Holzer U, Kasteleiner P, Schittenhelm J, Schaefer JF, Mueller I, Lang P, Handgretinger R.
PMID: 31791281
BMC Pediatr. 2019 Dec 02;19(1):470. doi: 10.1186/s12887-019-1851-6.

After publication of the original article (1), it was brought to our attention that references 24 and 31 are inappropriately cited in the article.

Cite
Schober S, Schilbach K, Doering M, et al. Correction to: Allogeneic hematopoietic stem cell transplantation in two brothers with DNA ligase IV deficiency: a case report and review of the literature. BMC Pediatr. 2019;19(1):470doi: 10.1186/s12887-019-1851-6.
Schober, S., Schilbach, K., Doering, M., Cabanillas Stanchi, K. M., Holzer, U., Kasteleiner, P., Schittenhelm, J., Schaefer, J. F., Mueller, I., Lang, P., & Handgretinger, R. (2019). Correction to: Allogeneic hematopoietic stem cell transplantation in two brothers with DNA ligase IV deficiency: a case report and review of the literature. BMC pediatrics, 19(1), 470. https://doi.org/10.1186/s12887-019-1851-6
Schober, Sarah, et al. "Correction to: Allogeneic hematopoietic stem cell transplantation in two brothers with DNA ligase IV deficiency: a case report and review of the literature." BMC pediatrics vol. 19,1 (2019): 470. doi: https://doi.org/10.1186/s12887-019-1851-6
Schober S, Schilbach K, Doering M, Cabanillas Stanchi KM, Holzer U, Kasteleiner P, Schittenhelm J, Schaefer JF, Mueller I, Lang P, Handgretinger R. Correction to: Allogeneic hematopoietic stem cell transplantation in two brothers with DNA ligase IV deficiency: a case report and review of the literature. BMC Pediatr. 2019 Dec 02;19(1):470. doi: 10.1186/s12887-019-1851-6. PMID: 31791281; PMCID: PMC6886177.
Copy Download .nbib Format: NLM
Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein.

bioRxiv : the preprint server for biology

Wec AZ, Wrapp D, Herbert AS, Maurer D, Haslwanter D, Sakharkar M, Jangra RK, Dieterle ME, Lilov A, Huang D, Tse LV, Johnson NV, Hsieh CL, Wang N, Nett JH, Champney E, Burnina I, Brown M, Lin S, Sinclair M, Johnson C, Pudi S, Bortz R, Wirchnianski AS, Laudermilch E, Florez C, Fels JM, O'Brien CM, Graham BS, Nemazee D, Burton DR, Baric RS, Voss JE, Chandran K, Dye JM, McLellan JS, Walker LM.
PMID: 32511337
bioRxiv. 2020 May 16; doi: 10.1101/2020.05.15.096511.

Broadly protective vaccines against known and pre-emergent coronaviruses are urgently needed. Critical to their development is a deeper understanding of cross-neutralizing antibody responses induced by natural human coronavirus (HCoV) infections. Here, we mined the memory B cell repertoire of...

Cite
Wec AZ, Wrapp D, Herbert AS, et al. Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein. bioRxiv. 2020;doi: 10.1101/2020.05.15.096511.
Wec, A. Z., Wrapp, D., Herbert, A. S., Maurer, D., Haslwanter, D., Sakharkar, M., Jangra, R. K., Dieterle, M. E., Lilov, A., Huang, D., Tse, L. V., Johnson, N. V., Hsieh, C. L., Wang, N., Nett, J. H., Champney, E., Burnina, I., Brown, M., Lin, S., Sinclair, M., Johnson, C., Pudi, S., Bortz, R., Wirchnianski, A. S., Laudermilch, E., Florez, C., Fels, J. M., O'Brien, C. M., Graham, B. S., Nemazee, D., Burton, D. R., Baric, R. S., Voss, J. E., Chandran, K., Dye, J. M., McLellan, J. S., & Walker, L. M. (2020). Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2020.05.15.096511
Wec, Anna Z, et al. "Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein." bioRxiv : the preprint server for biology vol. (2020). doi: https://doi.org/10.1101/2020.05.15.096511
Wec AZ, Wrapp D, Herbert AS, Maurer D, Haslwanter D, Sakharkar M, Jangra RK, Dieterle ME, Lilov A, Huang D, Tse LV, Johnson NV, Hsieh CL, Wang N, Nett JH, Champney E, Burnina I, Brown M, Lin S, Sinclair M, Johnson C, Pudi S, Bortz R, Wirchnianski AS, Laudermilch E, Florez C, Fels JM, O'Brien CM, Graham BS, Nemazee D, Burton DR, Baric RS, Voss JE, Chandran K, Dye JM, McLellan JS, Walker LM. Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein. bioRxiv. 2020 May 16; doi: 10.1101/2020.05.15.096511. PMID: 32511337; PMCID: PMC7241100.
Copy Download .nbib Format: NLM
Canadian Consensus Recommendations on the Management of .

Current oncology (Toronto, Ont.)

Cheema PK, Banerji SO, Blais N, Chu QS, Desmeules P, Juergens RA, Leighl NB, Sheffield BS, Wheatley-Price PF, Melosky BL.
PMID: 34898564
Curr Oncol. 2021 Nov 09;28(6):4552-4576. doi: 10.3390/curroncol28060386.

In Canada, the therapeutic management of patients with advanced non-small cell lung cancer (NSCLC) with rare actionable mutations differs between provinces, territories, and individual centres based on access to molecular testing and funded treatments. These variations, together with the...

Cite
Cheema PK, Banerji SO, Blais N, et al. Canadian Consensus Recommendations on the Management of . Curr Oncol. 2021;28(6):4552-4576doi: 10.3390/curroncol28060386.
Cheema, P. K., Banerji, S. O., Blais, N., Chu, Q. S., Desmeules, P., Juergens, R. A., Leighl, N. B., Sheffield, B. S., Wheatley-Price, P. F., & Melosky, B. L. (2021). Canadian Consensus Recommendations on the Management of . Current oncology (Toronto, Ont.), 28(6), 4552-4576. https://doi.org/10.3390/curroncol28060386
Cheema, Parneet K, et al. "Canadian Consensus Recommendations on the Management of ." Current oncology (Toronto, Ont.) vol. 28,6 (2021): 4552-4576. doi: https://doi.org/10.3390/curroncol28060386
Cheema PK, Banerji SO, Blais N, Chu QS, Desmeules P, Juergens RA, Leighl NB, Sheffield BS, Wheatley-Price PF, Melosky BL. Canadian Consensus Recommendations on the Management of . Curr Oncol. 2021 Nov 09;28(6):4552-4576. doi: 10.3390/curroncol28060386. PMID: 34898564; PMCID: PMC8628757.
Copy Download .nbib Format: NLM
Trustworthy COVID-19 Mapping: Geo-spatial Data Literacy Aspects of Choropleth Maps.

KN - journal of cartography and geographic information

Juergens C.
PMID: 33134849
KN J Cartogr Geogr Inf. 2020 Oct 23;1-7. doi: 10.1007/s42489-020-00057-w. Epub 2020 Oct 23.

Since the COVID-19 (coronavirus disease 2019) pandemic is a global phenomenon, many scientists and research organizations create thematic maps to visualize and understand the spatial spread of the disease and to inform mankind. Nowadays, Geographic Information Systems (GIS) and...

Cite
Juergens C. Trustworthy COVID-19 Mapping: Geo-spatial Data Literacy Aspects of Choropleth Maps. KN J Cartogr Geogr Inf. 2020;1-7doi: 10.1007/s42489-020-00057-w.
Juergens, C. (2020). Trustworthy COVID-19 Mapping: Geo-spatial Data Literacy Aspects of Choropleth Maps. KN - journal of cartography and geographic information, 1-7. https://doi.org/10.1007/s42489-020-00057-w
Juergens, Carsten. "Trustworthy COVID-19 Mapping: Geo-spatial Data Literacy Aspects of Choropleth Maps." KN - journal of cartography and geographic information vol. (2020): 1-7. doi: https://doi.org/10.1007/s42489-020-00057-w
Juergens C. Trustworthy COVID-19 Mapping: Geo-spatial Data Literacy Aspects of Choropleth Maps. KN J Cartogr Geogr Inf. 2020 Oct 23;1-7. doi: 10.1007/s42489-020-00057-w. Epub 2020 Oct 23. PMID: 33134849; PMCID: PMC7583689.
Copy Download .nbib Format: NLM
Impact of frailty and anticoagulation status on readmission and mortality rates following falls in patients over 80.

Proceedings (Baylor University. Medical Center)

Hall C, Essler S, Dandashi J, Corrigan M, Muñoz-Maldonado Y, Juergens A, Wieters S, Drigalla D, Regner JL.
PMID: 31191123
Proc (Bayl Univ Med Cent). 2019 Mar 21;32(2):181-186. doi: 10.1080/08998280.2018.1550468. eCollection 2019 Apr.

Falls are the leading cause of trauma-related mortality in geriatric patients. We hypothesized that frailty and anticoagulation status are risk factors for readmission and mortality following falls in patients >80 years. A retrospective review was performed on patients over...

Cite
Hall C, Essler S, Dandashi J, et al. Impact of frailty and anticoagulation status on readmission and mortality rates following falls in patients over 80. Proc (Bayl Univ Med Cent). 2019;32(2):181-186doi: 10.1080/08998280.2018.1550468.
Hall, C., Essler, S., Dandashi, J., Corrigan, M., Muñoz-Maldonado, Y., Juergens, A., Wieters, S., Drigalla, D., & Regner, J. L. (2019). Impact of frailty and anticoagulation status on readmission and mortality rates following falls in patients over 80. Proceedings (Baylor University. Medical Center), 32(2), 181-186. https://doi.org/10.1080/08998280.2018.1550468
Hall, Chad, et al. "Impact of frailty and anticoagulation status on readmission and mortality rates following falls in patients over 80." Proceedings (Baylor University. Medical Center) vol. 32,2 (2019): 181-186. doi: https://doi.org/10.1080/08998280.2018.1550468
Hall C, Essler S, Dandashi J, Corrigan M, Muñoz-Maldonado Y, Juergens A, Wieters S, Drigalla D, Regner JL. Impact of frailty and anticoagulation status on readmission and mortality rates following falls in patients over 80. Proc (Bayl Univ Med Cent). 2019 Mar 21;32(2):181-186. doi: 10.1080/08998280.2018.1550468. eCollection 2019 Apr. PMID: 31191123; PMCID: PMC6541068.
Copy Download .nbib Format: NLM
The Gut-Brain Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review.

Frontiers in aging neuroscience

Ambrosini YM, Borcherding D, Kanthasamy A, Kim HJ, Willette AA, Jergens A, Allenspach K, Mochel JP.
PMID: 31275138
Front Aging Neurosci. 2019 Jun 18;11:130. doi: 10.3389/fnagi.2019.00130. eCollection 2019.

Identifying appropriate animal models is critical in developing translatable

Cite
Ambrosini YM, Borcherding D, Kanthasamy A, et al. The Gut-Brain Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review. Front Aging Neurosci. 2019;11:130doi: 10.3389/fnagi.2019.00130.
Ambrosini, Y. M., Borcherding, D., Kanthasamy, A., Kim, H. J., Willette, A. A., Jergens, A., Allenspach, K., & Mochel, J. P. (2019). The Gut-Brain Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review. Frontiers in aging neuroscience, 11130. https://doi.org/10.3389/fnagi.2019.00130
Ambrosini, Yoko M, et al. "The Gut-Brain Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review." Frontiers in aging neuroscience vol. 11 (2019): 130. doi: https://doi.org/10.3389/fnagi.2019.00130
Ambrosini YM, Borcherding D, Kanthasamy A, Kim HJ, Willette AA, Jergens A, Allenspach K, Mochel JP. The Gut-Brain Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review. Front Aging Neurosci. 2019 Jun 18;11:130. doi: 10.3389/fnagi.2019.00130. eCollection 2019. PMID: 31275138; PMCID: PMC6591269.
Copy Download .nbib Format: NLM
Real-world use of ticagrelor versus clopidogrel in percutaneous coronary intervention-treated ST-elevation myocardial infarction patients: A single-center registry study.

Journal of the Saudi Heart Association

Hee L, Gibbs OJ, Assad JG, Sharma LD, Hopkins A, Juergens CP, Lo S, Mussap CJ.
PMID: 31296977
J Saudi Heart Assoc. 2019 Oct;31(4):151-160. doi: 10.1016/j.jsha.2019.05.005. Epub 2019 May 31.

OBJECTIVES: The primary aim was to investigate the efficacy and safety of dual antiplatelet therapy (DAPT) using ticagrelor (T-DAPT) versus clopidogrel (C-DAPT) in a real-world ST-elevation myocardial infarction (STEMI) population.METHODS: We retrospectively analyzed 655 consecutive patients having primary percutaneous...

Cite
Hee L, Gibbs OJ, Assad JG, et al. Real-world use of ticagrelor versus clopidogrel in percutaneous coronary intervention-treated ST-elevation myocardial infarction patients: A single-center registry study. J Saudi Heart Assoc. 2019;31(4):151-160doi: 10.1016/j.jsha.2019.05.005.
Hee, L., Gibbs, O. J., Assad, J. G., Sharma, L. D., Hopkins, A., Juergens, C. P., Lo, S., & Mussap, C. J. (2019). Real-world use of ticagrelor versus clopidogrel in percutaneous coronary intervention-treated ST-elevation myocardial infarction patients: A single-center registry study. Journal of the Saudi Heart Association, 31(4), 151-160. https://doi.org/10.1016/j.jsha.2019.05.005
Hee, Leia, et al. "Real-world use of ticagrelor versus clopidogrel in percutaneous coronary intervention-treated ST-elevation myocardial infarction patients: A single-center registry study." Journal of the Saudi Heart Association vol. 31,4 (2019): 151-160. doi: https://doi.org/10.1016/j.jsha.2019.05.005
Hee L, Gibbs OJ, Assad JG, Sharma LD, Hopkins A, Juergens CP, Lo S, Mussap CJ. Real-world use of ticagrelor versus clopidogrel in percutaneous coronary intervention-treated ST-elevation myocardial infarction patients: A single-center registry study. J Saudi Heart Assoc. 2019 Oct;31(4):151-160. doi: 10.1016/j.jsha.2019.05.005. Epub 2019 May 31. PMID: 31296977; PMCID: PMC6599087.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 187 entries